RTW INVESTMENTS, LP Q3 2021 Filing

Filed November 15, 2021

Portfolio Value

$6.6B

Holdings

120

Report Date

Q3 2021

Filing Type

13F-HR

All Holdings (120 positions)

#	Stock	Shares	Value	% Portfolio
101	—POINT BIOPHARMA GLOBAL INC	490,000	$3.8B	56.82%
102	MXCTGBXMAXCYTE INC	275,000	$3.4B	50.64%
103	—MONTES ARCHIMEDES ACQUISITIO	400,000	$3.2B	47.66%
104	SMFRUSDSEMA4 HOLDINGS CORP	400,000	$2.9B	44.28%
105	—MEDICUS SCIENCES ACQUISITION	300,000	$2.9B	44.11%
106	CVRXCVRX INC	150,000	$2.5B	37.42%
107	DNAYCODEX DNA INC	200,000	$2.2B	33.57%
108	TWSTTWIST BIOSCIENCE CORP	18,473	$2.0B	29.80%
109	—MIROMATRIX MED INC	280,000	$1.9B	29.39%
110	RXSTRXSIGHT INC	150,000	$1.9B	28.67%
111	MDXGMIMEDX GROUP INC	295,748	$1.8B	27.02%
112	PRNPROFOUND MED CORP	122,098	$1.8B	26.96%
113	BOLT1EURBOLT BIOTHERAPEUTICS INC	126,365	$1.6B	24.11%
114	—AKOYA BIOSCIENCES INC	100,000	$1.4B	21.05%
115	MASS908 DEVICES INC	40,000	$1.3B	19.62%
116	—SINGULAR GENOMICS SYSTEMS IN	100,000	$1.1B	16.88%
117	—ZYMERGEN INC	70,000	$922.0M	13.90%
118	BNRBURNING ROCK BIOTECH LTD	30,000	$536.0M	8.08%
119	—RENOVACOR INC	350,000	$224.0M	3.38%
120	—MEDICUS SCIENCES ACQUISITION	33,331	$24.0M	0.36%

PreviousPage 2 of 2